This report contains market size and forecasts of Bi-Specific Antibodies Therapy in Global, including the following market information:
Global Bi-Specific Antibodies Therapy Market Revenue, 2016-2021, 2022-2027, ($ millions)
Global top five companies in 2020 (%)
The global Bi-Specific Antibodies Therapy market was valued at 2518.9 million in 2020 and is projected to reach US$ 6203.8 million by 2027, at a CAGR of 25.3% during the forecast period.
MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Bi-Specific Antibodies Therapy companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Bi-Specific Antibodies Therapy Market, By Type, 2016-2021, 2022-2027 ($ millions)
Global Bi-Specific Antibodies Therapy Market Segment Percentages, By Type, 2020 (%)
Fragment-Based Antibodies
IgG-Based Antibodies
China Bi-Specific Antibodies Therapy Market, By Application, 2016-2021, 2022-2027 ($ millions)
China Bi-Specific Antibodies Therapy Market Segment Percentages, By Application, 2020 (%)
Cancer
Haemophilia
Other Non-Cancer Diseases
Global Bi-Specific Antibodies Therapy Market, By Region and Country, 2016-2021, 2022-2027 ($ Millions)
Global Bi-Specific Antibodies Therapy Market Segment Percentages, By Region and Country, 2020 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Total Bi-Specific Antibodies Therapy Market Competitors Revenues in Global, by Players 2016-2021 (Estimated), ($ millions)
Total Bi-Specific Antibodies Therapy Market Competitors Revenues Share in Global, by Players 2020 (%)
Further, the report presents profiles of competitors in the market, including the following:
Roche
Amgen
Sanofi
Pfizer
Johnson & Johnson
AstraZeneca
AbbVie
Lindis Biotech
MacroGenics, Inc
Genmab
Alphamab Co. Ltd
Akeso, Inc.
Table of Contents
1 Introduction to Research & Analysis Reports
1.1 Bi-Specific Antibodies Therapy Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Bi-Specific Antibodies Therapy Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Bi-Specific Antibodies Therapy Overall Market Size
2.1 Global Bi-Specific Antibodies Therapy Market Size: 2021 VS 2027
2.2 Global Bi-Specific Antibodies Therapy Market Size, Prospects & Forecasts: 2016-2027
2.3 Key Market Trends, Opportunity, Drivers and Restraints
2.3.1 Market Opportunities & Trends
2.3.2 Market Drivers
2.3.3 Market Restraints
3 Company Landscape
3.1 Top Bi-Specific Antibodies Therapy Players in Global Market
3.2 Top Global Bi-Specific Antibodies Therapy Companies Ranked by Revenue
3.3 Global Bi-Specific Antibodies Therapy Revenue by Companies
3.4 Top 3 and Top 5 Bi-Specific Antibodies Therapy Companies in Global Market, by Revenue in 2020
3.5 Global Companies Bi-Specific Antibodies Therapy Product Type
3.6 Tier 1, Tier 2 and Tier 3 Bi-Specific Antibodies Therapy Players in Global Market
3.6.1 List of Global Tier 1 Bi-Specific Antibodies Therapy Companies
3.6.2 List of Global Tier 2 and Tier 3 Bi-Specific Antibodies Therapy Companies
4 Market Sights by Product
4.1 Overview
4.1.1 By Type - Global Bi-Specific Antibodies Therapy Market Size Markets, 2021 & 2027
4.1.2 Fragment-Based Antibodies
4.1.3 IgG-Based Antibodies
4.2 By Type - Global Bi-Specific Antibodies Therapy Revenue & Forecasts
4.2.1 By Type - Global Bi-Specific Antibodies Therapy Revenue, 2016-2021
4.2.2 By Type - Global Bi-Specific Antibodies Therapy Revenue, 2022-2027
4.2.3 By Type - Global Bi-Specific Antibodies Therapy Revenue Market Share, 2016-2027
5 Sights by Application
5.1 Overview
5.1.1 By Application - Global Bi-Specific Antibodies Therapy Market Size, 2021 & 2027
5.1.2 Cancer
5.1.3 Haemophilia
5.1.4 Other Non-Cancer Diseases
5.2 By Application - Global Bi-Specific Antibodies Therapy Revenue & Forecasts
5.2.1 By Application - Global Bi-Specific Antibodies Therapy Revenue, 2016-2021
5.2.2 By Application - Global Bi-Specific Antibodies Therapy Revenue, 2022-2027
5.2.3 By Application - Global Bi-Specific Antibodies Therapy Revenue Market Share, 2016-2027
6 Sights by Region
6.1 By Region - Global Bi-Specific Antibodies Therapy Market Size, 2021 & 2027
6.2 By Region - Global Bi-Specific Antibodies Therapy Revenue & Forecasts
6.2.1 By Region - Global Bi-Specific Antibodies Therapy Revenue, 2016-2021
6.2.2 By Region - Global Bi-Specific Antibodies Therapy Revenue, 2022-2027
6.2.3 By Region - Global Bi-Specific Antibodies Therapy Revenue Market Share, 2016-2027
6.3 North America
6.3.1 By Country - North America Bi-Specific Antibodies Therapy Revenue, 2016-2027
6.3.2 US Bi-Specific Antibodies Therapy Market Size, 2016-2027
6.3.3 Canada Bi-Specific Antibodies Therapy Market Size, 2016-2027
6.3.4 Mexico Bi-Specific Antibodies Therapy Market Size, 2016-2027
6.4 Europe
6.4.1 By Country - Europe Bi-Specific Antibodies Therapy Revenue, 2016-2027
6.4.2 Germany Bi-Specific Antibodies Therapy Market Size, 2016-2027
6.4.3 France Bi-Specific Antibodies Therapy Market Size, 2016-2027
6.4.4 U.K. Bi-Specific Antibodies Therapy Market Size, 2016-2027
6.4.5 Italy Bi-Specific Antibodies Therapy Market Size, 2016-2027
6.4.6 Russia Bi-Specific Antibodies Therapy Market Size, 2016-2027
6.4.7 Nordic Countries Bi-Specific Antibodies Therapy Market Size, 2016-2027
6.4.8 Benelux Bi-Specific Antibodies Therapy Market Size, 2016-2027
6.5 Asia
6.5.1 By Region - Asia Bi-Specific Antibodies Therapy Revenue, 2016-2027
6.5.2 China Bi-Specific Antibodies Therapy Market Size, 2016-2027
6.5.3 Japan Bi-Specific Antibodies Therapy Market Size, 2016-2027
6.5.4 South Korea Bi-Specific Antibodies Therapy Market Size, 2016-2027
6.5.5 Southeast Asia Bi-Specific Antibodies Therapy Market Size, 2016-2027
6.5.6 India Bi-Specific Antibodies Therapy Market Size, 2016-2027
6.6 South America
6.6.1 By Country - South America Bi-Specific Antibodies Therapy Revenue, 2016-2027
6.6.2 Brazil Bi-Specific Antibodies Therapy Market Size, 2016-2027
6.6.3 Argentina Bi-Specific Antibodies Therapy Market Size, 2016-2027
6.7 Middle East & Africa
6.7.1 By Country - Middle East & Africa Bi-Specific Antibodies Therapy Revenue, 2016-2027
6.7.2 Turkey Bi-Specific Antibodies Therapy Market Size, 2016-2027
6.7.3 Israel Bi-Specific Antibodies Therapy Market Size, 2016-2027
6.7.4 Saudi Arabia Bi-Specific Antibodies Therapy Market Size, 2016-2027
6.7.5 UAE Bi-Specific Antibodies Therapy Market Size, 2016-2027
7 Players Profiles
7.1 Roche
7.1.1 Roche Corporate Summary
7.1.2 Roche Business Overview
7.1.3 Roche Bi-Specific Antibodies Therapy Major Product Offerings
7.1.4 Roche Bi-Specific Antibodies Therapy Revenue in Global (2016-2021)
7.1.5 Roche Key News
7.2 Amgen
7.2.1 Amgen Corporate Summary
7.2.2 Amgen Business Overview
7.2.3 Amgen Bi-Specific Antibodies Therapy Major Product Offerings
7.2.4 Amgen Bi-Specific Antibodies Therapy Revenue in Global (2016-2021)
7.2.5 Amgen Key News
7.3 Sanofi
7.3.1 Sanofi Corporate Summary
7.3.2 Sanofi Business Overview
7.3.3 Sanofi Bi-Specific Antibodies Therapy Major Product Offerings
7.3.4 Sanofi Bi-Specific Antibodies Therapy Revenue in Global (2016-2021)
7.3.5 Sanofi Key News
7.4 Pfizer
7.4.1 Pfizer Corporate Summary
7.4.2 Pfizer Business Overview
7.4.3 Pfizer Bi-Specific Antibodies Therapy Major Product Offerings
7.4.4 Pfizer Bi-Specific Antibodies Therapy Revenue in Global (2016-2021)
7.4.5 Pfizer Key News
7.5 Johnson & Johnson
7.5.1 Johnson & Johnson Corporate Summary
7.5.2 Johnson & Johnson Business Overview
7.5.3 Johnson & Johnson Bi-Specific Antibodies Therapy Major Product Offerings
7.5.4 Johnson & Johnson Bi-Specific Antibodies Therapy Revenue in Global (2016-2021)
7.5.5 Johnson & Johnson Key News
7.6 AstraZeneca
7.6.1 AstraZeneca Corporate Summary
7.6.2 AstraZeneca Business Overview
7.6.3 AstraZeneca Bi-Specific Antibodies Therapy Major Product Offerings
7.6.4 AstraZeneca Bi-Specific Antibodies Therapy Revenue in Global (2016-2021)
7.6.5 AstraZeneca Key News
7.7 AbbVie
7.7.1 AbbVie Corporate Summary
7.7.2 AbbVie Business Overview
7.7.3 AbbVie Bi-Specific Antibodies Therapy Major Product Offerings
7.4.4 AbbVie Bi-Specific Antibodies Therapy Revenue in Global (2016-2021)
7.7.5 AbbVie Key News
7.8 Lindis Biotech
7.8.1 Lindis Biotech Corporate Summary
7.8.2 Lindis Biotech Business Overview
7.8.3 Lindis Biotech Bi-Specific Antibodies Therapy Major Product Offerings
7.8.4 Lindis Biotech Bi-Specific Antibodies Therapy Revenue in Global (2016-2021)
7.8.5 Lindis Biotech Key News
7.9 MacroGenics, Inc
7.9.1 MacroGenics, Inc Corporate Summary
7.9.2 MacroGenics, Inc Business Overview
7.9.3 MacroGenics, Inc Bi-Specific Antibodies Therapy Major Product Offerings
7.9.4 MacroGenics, Inc Bi-Specific Antibodies Therapy Revenue in Global (2016-2021)
7.9.5 MacroGenics, Inc Key News
7.10 Genmab
7.10.1 Genmab Corporate Summary
7.10.2 Genmab Business Overview
7.10.3 Genmab Bi-Specific Antibodies Therapy Major Product Offerings
7.10.4 Genmab Bi-Specific Antibodies Therapy Revenue in Global (2016-2021)
7.10.5 Genmab Key News
7.11 Alphamab Co. Ltd
7.11.1 Alphamab Co. Ltd Corporate Summary
7.11.2 Alphamab Co. Ltd Business Overview
7.11.3 Alphamab Co. Ltd Bi-Specific Antibodies Therapy Major Product Offerings
7.11.4 Alphamab Co. Ltd Bi-Specific Antibodies Therapy Revenue in Global (2016-2021)
7.11.5 Alphamab Co. Ltd Key News
7.12 Akeso, Inc.
7.12.1 Akeso, Inc. Corporate Summary
7.12.2 Akeso, Inc. Business Overview
7.12.3 Akeso, Inc. Bi-Specific Antibodies Therapy Major Product Offerings
7.12.4 Akeso, Inc. Bi-Specific Antibodies Therapy Revenue in Global (2016-2021)
7.12.5 Akeso, Inc. Key News
8 Conclusion
9 Appendix
9.1 Note
9.2 Examples of Clients
9.3 Disclaimer
List of Tables
Table 1. Bi-Specific Antibodies Therapy Market Opportunities & Trends in Global Market
Table 2. Bi-Specific Antibodies Therapy Market Drivers in Global Market
Table 3. Bi-Specific Antibodies Therapy Market Restraints in Global Market
Table 4. Key Players of Bi-Specific Antibodies Therapy in Global Market
Table 5. Top Bi-Specific Antibodies Therapy Players in Global Market, Ranking by Revenue (2019)
Table 6. Global Bi-Specific Antibodies Therapy Revenue by Companies, (US$, Mn), 2016-2021
Table 7. Global Bi-Specific Antibodies Therapy Revenue Share by Companies, 2016-2021
Table 8. Global Companies Bi-Specific Antibodies Therapy Product Type
Table 9. List of Global Tier 1 Bi-Specific Antibodies Therapy Companies, Revenue (US$, Mn) in 2020 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Bi-Specific Antibodies Therapy Companies, Revenue (US$, Mn) in 2020 and Market Share
Table 11. By Type
Roche
Amgen
Sanofi
Pfizer
Johnson & Johnson
AstraZeneca
AbbVie
Lindis Biotech
MacroGenics, Inc
Genmab
Alphamab Co. Ltd
Akeso, Inc.